UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Development and Clinical Validation of a Blood Test for Early Detection of Colorectal Adenomas and Cancer for Screening and Postpolypectomy Surveillance

Gastro hep advances, 2022, Vol.1 (2), p.223-230

2022

Link zum Volltext

Verfügbarkeit prüfen

Mechanical stretch is a highly selective regulator of gene expression in human bladder smooth muscle cells

Physiological genomics, 2004-12, Vol.20 (1), p.36-44

2004

Link zum Volltext

Verfügbarkeit prüfen

S3338 A Great Mimicker: A Case of Autoimmune Pancreatitis Masquerading as Hepatic Cirrhosis

The American journal of gastroenterology, 2020-10, Vol.115 (1), p.S1738-S1738

2020

Link zum Volltext

Verfügbarkeit prüfen

832-P: Coadministration of Metformin with GLY-200, a Clinical-Stage Nonabsorbed Drug for the Treatment of Type 2 Diabetes (T2D), Has No Significant Impact on the Oral Absorption of Metformin in the Rat

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

A First-in-Human Study of GLY-200, an Oral, Gut- Restricted, Pharmacologic Duodenal Exclusion Therapy

Obesity (Silver Spring, Md.), 2022-11, Vol.30, p.19-19

2022

Link zum Volltext

Verfügbarkeit prüfen

220-OR: First-in-Human Study of a Pharmacological Duodenal Exclusion Therapy Mimics a Roux-en-Y Gastric Bypass Biomarker Signature

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility of gene expression across generations of Affymetrix microarrays

BMC bioinformatics, 2003-06, Vol.4 (1), p.27-27, Article 27

2003

Link zum Volltext

Verfügbarkeit prüfen

823-P: GLY-200, a Pharmacologic Duodenal Exclusion Therapy, Improved Metabolic Parameters in the DIO Rat

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

833-P: Duodenal Targeting by Oral Pharmacologic Duodenal Exclusion Therapy for Treatment of Type 2 Diabetes (T2D)

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

Significant Weight Loss Due to a Novel Oral Polymeric Mucin Binding Duodenal Exclusion Therapy

Obesity (Silver Spring, Md.), 2021-12, Vol.29, p.162-162

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical performance of a multimodal screening blood test for advanced adenomas and CRC in an average-risk cohort of 1,038 participants

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.75-75

2023

Link zum Volltext

Verfügbarkeit prüfen

Tough to Swallow: Esophageal Food Impaction from Esophageal Amyloidosis

Digestive diseases and sciences, 2017-05, Vol.62 (5), p.1165-1167

2017

Link zum Volltext

Verfügbarkeit prüfen

Primary endoscopic therapies for obesity and metabolic diseases

Current opinion in gastroenterology, 2015-09, Vol.31 (5), p.351-358

2015

Link zum Volltext

Verfügbarkeit prüfen

Precision Bariatrics: Toward a New Paradigm of Personalized Devices in Obesity Therapeutics

Obesity surgery, 2016-07, Vol.26 (7), p.1642-1645

2016

Link zum Volltext

Verfügbarkeit prüfen

PeriLeve: An Implantable Peritoneovesicular Biopowered Shunt to Manage Patients with Refractory Ascites

Gastroenterology (New York, N.Y. 1943), 2019-07, Vol.157 (1), p.21-22

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of differential contribution of a circulating epithelial cell signal component in a multimodal colorectal neoplasia assay

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e15527-e15527

2022

Link zum Volltext

Verfügbarkeit prüfen

Multisite external validation of blood test for colorectal neoplasia screening in a majority average-risk screening cohort of 449 subjects

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.66-66

2024

Link zum Volltext

Verfügbarkeit prüfen

1209-P: Profound Metabolic Benefits Observed in an Eight-Week GK Rat Study of a Novel Orally Administered Polymeric Duodenal Exclusion Therapy: Implications for Type 2 Diabetes (T2D) Therapy

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Link zum Volltext

Verfügbarkeit prüfen

685 A SENSITIVE AND QUANTITATIVE NON-INVASIVE MULTIMODAL BLOOD TEST THAT DETECTS CANCER AND RECAPITULATES ADENOMA PROGNOSIS AVAILABLE FROM COLONOSCOPY

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-136-S-137

2021

Link zum Volltext

Verfügbarkeit prüfen

First‐in‐human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations

Diabetes, obesity & metabolism, 2023-09, Vol.25 (9), p.2447-2456

2023

Link zum Volltext

Verfügbarkeit prüfen

Development and clinical validation of a blood test for early detection of colorectal adenomas and cancer

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.50-50

2021

Link zum Volltext

Verfügbarkeit prüfen

818-P: Chronic Oral Polymeric Duodenal Exclusion Therapy Has Profound Metabolic Benefits in a T2D Rat Model and Affects Duodenal Morphological Enteroplasticity Similar to RYGB surgery: Implications for T2D Therapy

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Link zum Volltext

Verfügbarkeit prüfen

789: PERFORMANCE OF A NONINVASIVE BLOOD-BASED MULTI-MODAL TEST FOR AN AVERAGE RISK SCREENING POPULATION ENRICHED WITH CASE-CONTROL FOR CRC AND AA

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-190-S-190

2022

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor cell count from a blood sample for colorectal cancer (CRC) prevention: A 627-patient prospective study

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.485-485

2019

Link zum Volltext

Verfügbarkeit prüfen

A sensitive and quantitative multimodal blood test for the detection of colorectal adenomas and cancer: Correlation with size and number of polyps

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1555-1555

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development and Clinical Validation of a Blood Test for Early Detection of Colorectal Adenomas and Cancer for Screening and Postpolypectomy Surveillance

Mechanical stretch is a highly selective regulator of gene expression in human bladder smooth muscle cells

S3338 A Great Mimicker: A Case of Autoimmune Pancreatitis Masquerading as Hepatic Cirrhosis

832-P: Coadministration of Metformin with GLY-200, a Clinical-Stage Nonabsorbed Drug for the Treatment of Type 2 Diabetes (T2D), Has No Significant Impact on the Oral Absorption of Metformin in the Rat

A First-in-Human Study of GLY-200, an Oral, Gut- Restricted, Pharmacologic Duodenal Exclusion Therapy

220-OR: First-in-Human Study of a Pharmacological Duodenal Exclusion Therapy Mimics a Roux-en-Y Gastric Bypass Biomarker Signature

Reproducibility of gene expression across generations of Affymetrix microarrays

823-P: GLY-200, a Pharmacologic Duodenal Exclusion Therapy, Improved Metabolic Parameters in the DIO Rat

833-P: Duodenal Targeting by Oral Pharmacologic Duodenal Exclusion Therapy for Treatment of Type 2 Diabetes (T2D)

Significant Weight Loss Due to a Novel Oral Polymeric Mucin Binding Duodenal Exclusion Therapy

Clinical performance of a multimodal screening blood test for advanced adenomas and CRC in an average-risk cohort of 1,038 participants

Tough to Swallow: Esophageal Food Impaction from Esophageal Amyloidosis

Primary endoscopic therapies for obesity and metabolic diseases

Precision Bariatrics: Toward a New Paradigm of Personalized Devices in Obesity Therapeutics

PeriLeve: An Implantable Peritoneovesicular Biopowered Shunt to Manage Patients with Refractory Ascites

Evaluation of differential contribution of a circulating epithelial cell signal component in a multimodal colorectal neoplasia assay

Multisite external validation of blood test for colorectal neoplasia screening in a majority average-risk screening cohort of 449 subjects

1209-P: Profound Metabolic Benefits Observed in an Eight-Week GK Rat Study of a Novel Orally Administered Polymeric Duodenal Exclusion Therapy: Implications for Type 2 Diabetes (T2D) Therapy

685 A SENSITIVE AND QUANTITATIVE NON-INVASIVE MULTIMODAL BLOOD TEST THAT DETECTS CANCER AND RECAPITULATES ADENOMA PROGNOSIS AVAILABLE FROM COLONOSCOPY

First‐in‐human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations

Development and clinical validation of a blood test for early detection of colorectal adenomas and cancer

818-P: Chronic Oral Polymeric Duodenal Exclusion Therapy Has Profound Metabolic Benefits in a T2D Rat Model and Affects Duodenal Morphological Enteroplasticity Similar to RYGB surgery: Implications for T2D Therapy

789: PERFORMANCE OF A NONINVASIVE BLOOD-BASED MULTI-MODAL TEST FOR AN AVERAGE RISK SCREENING POPULATION ENRICHED WITH CASE-CONTROL FOR CRC AND AA

Circulating tumor cell count from a blood sample for colorectal cancer (CRC) prevention: A 627-patient prospective study

A sensitive and quantitative multimodal blood test for the detection of colorectal adenomas and cancer: Correlation with size and number of polyps

Suchergebnisse filtern